Pascal Soriot

Chief Executive Officer

Cambridge, United Kingdom

Pascal Soriot has served as Chief Executive Officer of AstraZeneca since October 2012, leading the company through significant growth and innovation in global biopharmaceuticals. He holds an MBA and a Doctor of Veterinary Medicine degree, and previously held senior roles at Roche and Aventis. Under his leadership, AstraZeneca has expanded its oncology and rare disease portfolios and executed major acquisitions, including Amolyt Pharma and Fusion Pharmaceuticals. Soriot is recognized for his strategic vision and commitment to advancing life-changing medicines.

Expertise

• Leadership
• Strategy
• Pharmaceuticals
• Operations
• Innovation